A mom owed nearly $102,000 for hospital care. Her state attorney general said to pay up.

Mer­ck KGaA’s Phase 3 tri­als of xev­ina­pant, the can­cer drug it li­censed from De­bio­pharm in 2021, are wind­ing down af­ter the drug showed that it

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it